| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55a505d7cf71e34fd51a620132cbe2c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3155f0c2660bc45fd48cf1ca0fee8fc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-90 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N61-00 |
| filingDate |
2004-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48dfed9d792deef608e35b594f946a0b |
| publicationDate |
2004-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004094601-A2 |
| titleOfInvention |
Methods of treating pin1 associated disorders by covalent modification of active site residues |
| abstract |
The invention pertains to methods of treating peptidyl-prolyl cis-trans isomerase Pin1 associated disorders through the administration of modulators specific for Pin-1 that covalently interact with a target site (MSPCIT’s). The invention further pertains to novel compounds that are able to modulate Pinl activity by forming a specific covalent interaction with an amino acid residue in the active site of Pinl. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104288134-A |
| priorityDate |
2003-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |